Takip et
Navonil De Sarkar
Navonil De Sarkar
PCF Young Investigator, Research Member, MCW Cancer Center, Asst. prof. Medical College of Wisconsin
mcw.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Inherited DNA-repair gene mutations in men with metastatic prostate cancer
CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, ...
New England Journal of Medicine 375 (5), 443-453, 2016
15652016
Genomic correlates of clinical outcome in advanced prostate cancer
W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ...
Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019
10102019
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Nature Medicine, 2016
6882016
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Cell 173, 1770–1782, 2018
4772018
Combined TP53 and RB1 loss promotes prostate cancer resistance to a spectrum of therapeutics and confers vulnerability to replication stress
MD Nyquist, A Corella, I Coleman, N De Sarkar, A Kaipainen, G Ha, ...
Cell reports 31 (8), 2020
1792020
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
SC Baca, DY Takeda, JH Seo, J Hwang, SY Ku, R Arafeh, T Arnoff, ...
Nature communications 12 (1), 1979, 2021
882021
Concordance of DNA repair gene mutations in paired primary prostate cancer samples and metastatic tissue or cell-free DNA
MT Schweizer, S Sivakumar, H Tukachinsky, I Coleman, N De Sarkar, ...
JAMA oncology 7 (9), 1378-1382, 2021
522021
A quest for miRNA bio-marker: a track back approach from gingivo buccal cancer to two different types of precancers
N De Sarkar, R Roy, JK Mitra, S Ghose, A Chakraborty, RR Paul, ...
PloS one 9 (8), e104839, 2014
442014
Regulation of CEACAM5 and therapeutic efficacy of an anti-CEACAM5–SN38 antibody–drug conjugate in neuroendocrine prostate cancer
DC DeLucia, TM Cardillo, L Ang, MP Labrecque, A Zhang, JE Hopkins, ...
Clinical Cancer Research 27 (3), 759-774, 2021
432021
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy
BR Winters, N De Sarkar, S Arora, H Bolouri, S Jana, F Vakar-Lopez, ...
JCI insight 4 (13), 2019
382019
MicroRNA and target gene expression based clustering of oral cancer, precancer and normal tissues
R Roy, R Singh, E Chattopadhyay, A Ray, N De Sarkar, R Aich, RR Paul, ...
Gene 593 (1), 58-63, 2016
382016
A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
AL Doebley, M Ko, H Liao, AE Cruikshank, K Santos, C Kikawa, JB Hiatt, ...
Nature Communications 13 (1), 7475, 2022
372022
Expression deregulation of mir31 and CXCL12 in two types of oral precancers and cancer: importance in progression of precancer and cancer
E Chattopadhyay, R Singh, A Ray, R Roy, N De Sarkar, RR Paul, M Pal, ...
Scientific Reports 6 (1), 32735, 2016
362016
Genetic variations at microRNA and processing genes and risk of oral cancer
R Roy, N De Sarkar, S Ghose, RR Paul, M Pal, C Bhattacharya, ...
Tumor Biology 35, 3409-3414, 2014
332014
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth
MD Nyquist, LS Ang, A Corella, IM Coleman, MP Meers, AJ Christiani, ...
The Journal of clinical investigation 131 (10), 2021
312021
Effects of arsenic toxicity on germination, seedling growth and peroxidase activity in Cicer arietinum
S Bhattacharya, N De Sarkar, P Banerjee, S Banerjee, S Mukherjee, ...
Int J Agric Food Sci 2 (4), 131-137, 2012
292012
Association between risk of oral precancer and genetic variations in microRNA and related processing genes
R Roy, N De Sarkar, S Ghose, RR Paul, A Ray, I Mukhopadhyay, B Roy
Journal of biomedical science 21, 1-7, 2014
242014
Clinical determinants for successful circulating tumor DNA analysis in prostate cancer
MT Schweizer, R Gulati, M Beightol, EQ Konnick, HH Cheng, N Klemfuss, ...
The Prostate 79 (7), 701-708, 2019
222019
Targeted gene sequencing of gallbladder carcinoma identifies high-impact somatic and rare germline mutations
S Yadav, N De Sarkar, N Kumari, N Krishnani, A Kumar, B Mittal
Cancer Genomics & Proteomics 14 (6), 495-506, 2017
222017
Genome-wide mitochondrial DNA sequence variations and lower expression of OXPHOS genes predict mitochondrial dysfunction in oral cancer tissue
E Chattopadhyay, N De Sarkar, R Singh, A Ray, R Roy, RR Paul, M Pal, ...
Tumor Biology 37, 11861-11871, 2016
172016
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20